Table 3.
Clinical pathology data of five dogs included in the study, before and after (b/a) the intratumoral inoculations of the reengineered anthrax toxin.
| Dog | PCV (%) (b/a) |
Leukocytes (×1000cels/μL) (b/a) |
Alanine transferase (U/L) (b/a) |
Alkaline Phosphatase (U/L) (b/a) |
Urea (mg/dl) (b/a) |
Creatinin (mg/dl) (b/a) |
Platelet (×1000/mL) (b/a) |
Weeks after Treatments |
|---|---|---|---|---|---|---|---|---|
| 1 | 46/40 | 19,9/28,4 | 43/12 | 29/69 | 43/47 | 1,0/0,8 | 366/285 | 5 |
| 2 | 50/43 | 34/12,9 | 31/56 | 248/655 | 58/34 | 0,7/0,9 | 569/407 | 9 |
| 3 | 34/25 | 29,6/14,1 | 99/264 | 395/691 | 64/94 | 1,3/1,3 | 678/474 | 14 |
| 4 | 43/41 | 13,7/6,1 | 57/60 | 110/92 | 25/35 | 0,8/0,8 | 392/312 | 21 |
| 5 | 47/44 | 6,3/8,69 | 56/52 | 131/138 | 43/155 | 1,2/1,0 | 438/553 | 22 |